Heart Disease News and Research

Latest Heart Disease News and Research

Safe-exercise tips from AAOS

With temperatures warming and recreational athletes coming out of hibernation, sports medicine physicians are treating more sprains, strains, fractures, tendonitis and other injuries.

16 Apr 2012

Two research studies on genetic components of Alzheimer's

Two research studies, co-led by UC Davis neurologist Charles DeCarli and conducted by an international team that included more than 80 scientists at 71 institutions in eight countries, has advanced understanding of the genetic components of Alzheimer's disease and of brain development. Both studies appear in the April 15 edition of the journal Nature Genetics.

16 Apr 2012

Four loci appear to decrease hippocampal volume

An international team of researchers led by Boston University School of Medicine (BUSM) has identified four loci that appear to be associated with decreasing the volume of the hippocampus.

16 Apr 2012

Europe's largest hypertension conference to take place in London

Europe's largest hypertension conference, the 22nd Scientific Meeting of the European Society of Hypertension (ESH) will take place in London, UK, from April 26 to 29, 2012.

16 Apr 2012

First study to show genetic adaptation of human fat metabolism

About 300 000 years ago humans adapted genetically to be able to produce larger amounts of Omega-3 and Omega-6 fatty acids. This adaptation may have been crucial to the development of the unique brain capacity in modern humans. In today's life situation, this genetic adaptation contributes instead to a higher risk of developing disorders like cardiovascular disease.

16 Apr 2012

New findings on out-of-hand nut consumption and health

In a study published in Nutrition Research, researchers looked at the association of out-of-hand nut (OOHN) consumption with nutrient intake, diet quality and the prevalence of risk factors for cardiovascular disease and metabolic syndrome in both children and adults.

16 Apr 2012

Mylan receives final FDA approval for generic Lescol Capsules ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluvastatin Capsules USP, 20 mg and 40 mg, the first generic version of Novartis' Lescol Capsules.

16 Apr 2012

Roundup: Texas considers relaxing rules for stem cell treatments; States weigh bills to protect consumers against high drug costs

A Texas agency will vote Friday on whether to enact new rules that would make it easier for doctors to offer experimental treatments using adult stem cells without federal approval. The Texas Medical Board, which licenses and disciplines doctors in the state, recently drafted stem-cell rules at the behest of Dr. Stanley Jones of Houston, who in July injected Gov. Rick Perry with the governor's own stem cells to try to aid his recovery from a back injury.

16 Apr 2012

Asthma treatment still inadequate in Australia

Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.

15 Apr 2012

Obesity surgery shows threefold rise over five years

There has been a threefold rise in Australians resorting to surgery to tackle their obesity. This has prompted the establishment of a registry to monitor the safety and effectiveness of weight-loss procedures.

15 Apr 2012

Flu shots offered to populations at risk at the beginning of season

All Care Inala Medical Centre doctor Michael Ho said flu shots were becoming more popular each year. “Flu seasons tends to begin in late March early April to June,” he said. “More and more people are opting to get vaccinations because they are promoted well within the community.” He added, “It is particularly important for elderly people to be immunized because their immune system is already not at its best…This is also the case for people who have chronic medical conditions like diabetes, severe asthma, or heart disease. With their current condition, if they catch the flu they can end up with a worse outcome.”

12 Apr 2012

FDA approves HUD designation for SynCardia temporary Total Artificial Heart for destination therapy

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant.

12 Apr 2012

Roundup: No new policies from cross-border insurance law; Dental Medicaid abuse in Texas?

Proponents said these out-of-state policies, stripped of Georgia's mandates, would have lower premiums – and allow more people to afford individual health insurance coverage. ... But a year later, nothing has happened. No insurer here has started selling a non-Georgia health plan.

12 Apr 2012

U.N. Secretary-General taps U.K. PM Cameron to chair committee to develop new set of MDGs

U.K. Prime Minister David Cameron has been asked by U.N. Secretary-General Ban Ki-moon to chair a "U.N. committee tasked with establishing a new set of U.N. millennium development goals [MDGs] to follow the present goals, which expire in 2015," the Guardian reports.

12 Apr 2012

C3BS' new production facilities in Mont-Saint-Guibert granted GMP Certification

The Belgian biotechnology company Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiac diseases, today announces that it has been granted Good Manufacturing Practice (GMP) Certification for its new production facilities in Mont-Saint-Guibert.

12 Apr 2012

Mass. hospitals mull acquisition, layoffs in changing market; Calif. hospital districts questioned

In Massachusetts, Partners HealthCare is in talks to acquire South Shore hospital and Beth Israel Deaconess cuts jobs after an admissions dip. In California, lawmakers probe taxpayer-funded hospital districts and their stockpiling of cash.

12 Apr 2012

AstraZeneca introduces DUTOPROL for hypertension

AstraZeneca today announced the availability of DUTOPROL (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL (metoprolol succinate) plus a low-dose diuretic that provides proven blood pressure lowering at 24 hours.

12 Apr 2012

Abiomed's Impella cVAD device awarded CE Mark

Abiomed, Inc., a leading provider of break-through heart support technologies, today announced it has received CE Marking approval in the European Union to market the Impella cVAD device, a new percutaneous Impella® heart pump that provides peak flow of approximately 4 liters of blood per minute.

12 Apr 2012

First Edition: April 12, 2012

Today's headlines include reports about Massachusetts' health reform's sixth birthday.

From Medtronic 12 Apr 2012

PPIs improve sleep and daytime quality of life for sufferers of GERD

The use of proton pump inhibitors improves the sleep and daytime quality of life for sufferers of gastroesophageal reflux disease, according to a systematic literature review in the April 2012 issue of Otolaryngology-Head and Neck Surgery.

12 Apr 2012